These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 22510806

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Microsome-associated lumenal lipid droplets in the regulation of lipoprotein secretion.
    Yao Z, Zhou H, Figeys D, Wang Y, Sundaram M.
    Curr Opin Lipidol; 2013 Apr; 24(2):160-70. PubMed ID: 23123764
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Apolipoprotein C-III in triglyceride-rich lipoprotein metabolism.
    Ramms B, Gordts PLSM.
    Curr Opin Lipidol; 2018 Jun; 29(3):171-179. PubMed ID: 29547399
    [Abstract] [Full Text] [Related]

  • 6. Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions.
    Sundaram M, Zhong S, Bou Khalil M, Links PH, Zhao Y, Iqbal J, Hussain MM, Parks RJ, Wang Y, Yao Z.
    J Lipid Res; 2010 Jan; 51(1):150-61. PubMed ID: 19622837
    [Abstract] [Full Text] [Related]

  • 7. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
    Rubinstein A, Gibson JC, Paterniti JR, Kakis G, Little A, Ginsberg HN, Brown WV.
    J Clin Invest; 1985 Feb; 75(2):710-21. PubMed ID: 3973025
    [Abstract] [Full Text] [Related]

  • 8. Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD.
    Taskinen MR, Packard CJ, Borén J.
    Curr Atheroscler Rep; 2019 May 20; 21(8):27. PubMed ID: 31111320
    [Abstract] [Full Text] [Related]

  • 9. ANGPTL3 and Apolipoprotein C-III as Novel Lipid-Lowering Targets.
    Akoumianakis I, Zvintzou E, Kypreos K, Filippatos TD.
    Curr Atheroscler Rep; 2021 Mar 10; 23(5):20. PubMed ID: 33694000
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhibitory effects of specific apolipoprotein C-III isoforms on the binding of triglyceride-rich lipoproteins to the lipolysis-stimulated receptor.
    Mann CJ, Troussard AA, Yen FT, Hannouche N, Najib J, Fruchart JC, Lotteau V, André P, Bihain BE.
    J Biol Chem; 1997 Dec 12; 272(50):31348-54. PubMed ID: 9395464
    [Abstract] [Full Text] [Related]

  • 15. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
    Julius U.
    Exp Clin Endocrinol Diabetes; 2003 Aug 12; 111(5):246-50. PubMed ID: 12951628
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Characterization of a hypertriglyceridemic transgenic miniature pig model expressing human apolipoprotein CIII.
    Wei J, Ouyang H, Wang Y, Pang D, Cong NX, Wang T, Leng B, Li D, Li X, Wu R, Ding Y, Gao F, Deng Y, Liu B, Li Z, Lai L, Feng H, Liu G, Deng X.
    FEBS J; 2012 Jan 12; 279(1):91-9. PubMed ID: 22023023
    [Abstract] [Full Text] [Related]

  • 20. Composition of human low density lipoprotein: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein.
    Karpe F, Tornvall P, Olivecrona T, Steiner G, Carlson LA, Hamsten A.
    Atherosclerosis; 1993 Jan 04; 98(1):33-49. PubMed ID: 8457249
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.